ASTS NewsBrief
Apr. 9, 2012

Kidney transplant experts urge single registry
The New York Times
Leaders in the field of kidney transplantation recommended last week that a single nationwide registry should oversee the complex matching process needed to expand the use of transplant chains and other forms of paired donation. But after a two-day conference, there was little consensus on how, when, or even whether the fragmented young field should unify.More

2012 Pfizer Advancing Research in Transplantation Science (ARTS) Awards
ASTS is pleased to share this unique research opportunity specific to transplantation. The Pfizer Advancing Research in Transplantation Science (ARTS) award program is a competitive, independent, peer-reviewed program designed to support clinical and basic science research exploring mTOR pathway inhibition, both mechanistic and clinical.

The deadline to apply is Monday, April 30, 2012. To access the application, eligibility guidelines, and additional information, visit

Increased Risk Consensus Conference registration deadline extended
The registration deadline has been extended for the Increased Risk Consensus Conference conducted by Northwestern, ASTS, and AST and made possible by a grant from the Agency for Healthcare Research and Quality (AHRQ). The conference is open to the public and will be held April 27, 2012, from 9 a.m. to 4 p.m. at the Crowne Plaza Chicago O'Hare in Chicago, Illinois. The new registration deadline is April 15, 2012. For more information, visit Risk Consensus Conference/index.html.More

Petition to increase NIH funding to $33 billion
Funding for the National Institutes of Health (NIH) has been at decreasing, flat, or sub-inflationary rates since 2003. This petition urges the President to propose a $33 billion NIH budget for fiscal year 2013 instead of the proposed flat $30.7 billion budget. ASTS encourages all members to sign the petition before April 17.More

Kidney donation does not increase CV risk
Renal & Urology News
Kidney donors are at no greater risk for cardiovascular (CV) events or death than non-donors, a research team led by Amit X. Garg, MD, reported online in the British Medical Journal. Interim results from a study of 2,028 living kidney donors in Ontario, Canada, and 20,280 matched non-donors followed for a median of 6.5 years (maximum 17.7 years) showed that the risk of major CV events or death was 34 percent lower in donors than in non-donors. More

Estimates of early death, acute liver failure and long-term mortality among live liver donors
Researchers sought to estimate the risk of perioperative mortality or acute liver failure for live liver donors in the United States and avoid selection or ascertainment biases and sample size limitations.More

Implications of a positive crossmatch in liver transplantation: A 20-year review
Liver Transplantation
Whether a positive crossmatch result has any relevance to liver transplantation (LT) outcomes remains controversial. We assessed the impact of a positive crossmatch result on patient and graft survival and posttransplant complications. During a 20-year period, 2723 LT procedures with crossmatch results were identified: 2479 primary transplants and 244 retransplants. More

Biliary atresia linked to food allergy post liver transplant
Medscape (free registration required)
The reason pediatric liver transplant patients have high rates of new-onset food allergy might be hidden in their indication for transplant, Japanese researchers reported here at the American Academy of Allergy, Asthma and Immunology 2012 Annual Meeting.More

Split liver transplantation using extended right grafts: The natural history of segment 4 and its impact on early postoperative outcomes
Liver Transplantation (paid subscription required)
Split liver transplantation using extended right grafts is associated with complications related to ischemia of hepatic segment 4 (S4), and these complications are associated with poor outcomes. We retrospectively analyzed 36 SLT recipients so that we could assess the association of radiological, biological and clinical features with S4 ischemia.More

Blood test for kidney transplant rejection now available
Modern Medicine
Quest Diagnostics recently announced the availability of a molecular blood test for identifying renal organ transplant rejection. The Renal Transplant Monitoring laboratory-developed test is designed to help physicians detect kidney failure weeks before conventional tests or clinical symptoms signify damage. The test may potentially improve patient care for kidney transplant patients while helping to lower sizable health care costs associated with renal transplant failure, Quest Diagnostics said in a statement.More

Dallas Wiens' face transplant progress revealed in new images
CBS News
In the year since Dallas Wiens became the first American to undergo a full face transplant, he's made much progress along the way with a return of some sensation and movement. Now he has the pictures to prove it. Wiens addressed the media at Brigham and Women's Hospital, where his surgery took place a little more than a year earlier.More